Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,337.11
-0.4%
-28.01
Arrow-Thin-Down
DJI
49,596.97
-0.6%
-313.62
Arrow-Thin-Down
NASDAQ
25,806.20
-0.1%
-32.75
Arrow-Thin-Down
Bitcoin
$79,921.00
-1.6%
-$1,291.82
Arrow-Thin-Down
AAPL
$287.40
-0.0%
-$0.11
Arrow-Thin-Down
AMZN
$271.14
-1.4%
-$3.85
Arrow-Thin-Down
GOOG
$395.33
+0.0%
+$0.19
Arrow-Thin-Down
META
$616.46
+0.6%
+$3.58
Arrow-Thin-Down
MSFT
$420.96
+1.7%
+$7.00
Arrow-Thin-Down
NVDA
$211.56
+1.8%
+$3.73
Arrow-Thin-Down
TSLA
$411.25
+3.1%
+$12.52
Most Active StocksDaily Stock GainersDaily Stock Losers
Starpharma logo

Starpharma

(OTC) SPHRY

Current Price$5.70
Market Cap$239.93M
Since IPO (2005)-10%
5 Year-57%
1 Year+846%
1 Month+68%

Starpharma Financials at a Glance

Market Cap

$239.93M

Revenue (TTM)

$16.50M

Net Income (TTM)

$13.48M

EPS (TTM)

$-0.05

P/E Ratio

-117.77

Dividend

$0.00

Beta (Volatility)

0.30 (Low)

Price

$5.70

Volume

382

Open

$5.70

Previous Close

$5.70

Daily Range

$5.70 - $5.70

52-Week Range

$0.47 - $5.70

SPHRY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Starpharma

Industry

Pharmaceuticals

Sector

Health Care

Employees

40

CEO

Cheryl Maley, MBA

Website

www.starpharma.com

Headquarters

Abbotsford, VIC 3067, AU

SPHRY Financials

Key Financial Metrics (TTM)

Gross Margin

60%

Operating Margin

-1%

Net Income Margin

-23%

Return on Equity

-14%

Return on Capital

-66%

Return on Assets

-12%

Earnings Yield

-0.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$239.93M

Shares Outstanding

42.09M

Volume

382

Avg. Volume

1.06K

Financials (TTM)

Gross Profit

$3.73M

Operating Income

$22.07M

EBITDA

$9.72M

Operating Cash Flow

$6.76M

Capital Expenditure

$42.00K

Free Cash Flow

$6.80M

Cash & ST Invst.

$15.41M

Total Debt

$2.40M

Starpharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$10.63M

+47.7%

Gross Profit

$9.85M

+53.3%

Gross Margin

92.68%

N/A

Market Cap

$239.93M

N/A

Market Cap/Employee

$6.00M

N/A

Employees

40

N/A

Net Income

$1.34M

+229.8%

EBITDA

$3.47M

-31.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$17.44M

-39.9%

Accounts Receivable

$4.17M

+160.9%

Inventory

$1.82M

-32.7%

Long Term Debt

$0.00

-100.0%

Short Term Debt

$789.22K

+3.0%

Return on Assets

-12.35%

N/A

Return on Invested Capital

-66.23%

N/A

Free Cash Flow

$3.61M

+72.6%

Operating Cash Flow

$3.84M

+83.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BIOYFBioSyent Inc.
$10.70-0.09%
BSEMBioStem Technologies, Inc.
$4.11-0.96%
IUGNFImugene Limited
$0.09+5.88%
PRNAFAlterity Therapeutics Limited
$0.00-18.18%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$12.34-0.06%
NVDANvidia
$211.56+0.02%
INTCIntel
$109.59-0.03%
TSLATesla
$411.25+0.03%

Questions About SPHRY

What is the current price of Starpharma?

Starpharma is trading at $5.70 per share.

What is the 52-week range for Starpharma?

Over the past 52 weeks, Starpharma has traded between $0.47 and $5.70.

How much debt does Starpharma have?

As of the most recent reporting period, Starpharma reported total debt of $1.57M.

How much cash does Starpharma have on hand?

Starpharma reported $10.10M in cash and cash equivalents in its most recent financial results.

What is Starpharma’s dividend yield?

Starpharma does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services